<DOC>
	<DOCNO>NCT02028533</DOCNO>
	<brief_summary>This pilot feasibility study assess tolerability chronic administration intranasal oxytocin patient receive methadone opioid replacement clinic actively use cocaine .</brief_summary>
	<brief_title>Cocaine Opioid Oxytocin Option - Limited</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Enrolled patient San Francisco General Hospital Opioid Treatment Outpatient Program Stable dose methadone least past two week At least one routine urine toxicology screen positive cocaine past month Positive urine pregnancy test Use illicit drug past month ( exception cocaine cannabis ) Currently meet Diagnostic Statistical Manual5 ( DSMV ) criterion severe major depressive disorder suicidal thought action History psychotic moderatesevere alcohol use disorder define DSMV criterion Severe neuropsychological disorder , brain trauma , epilepsy Sensitivity preservative ( particular E 216 , E 218 chlorobutanol hemihydrate ) Nasal obstruction , discharge , bleed Habitually drink large volume water Taking testosterone , estrogen/progesterone supplement , serotonin1a receptor agonists/antagonists</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>addiction</keyword>
	<keyword>oxytocin</keyword>
	<keyword>tolerability</keyword>
</DOC>